Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/1999
09/23/1999CA2323238A1 Methods and compositions for diagnosis of rheumatoid arthritis
09/23/1999CA2323093A1 Compounds and methods for therapy and diagnosis of lung cancer
09/23/1999CA2323083A1 Isolated mammalian membrane protein genes and related reagents
09/23/1999CA2322699A1 Compositions and methods for enhanced antigen delivery to antigen presenting cells in vivo
09/23/1999CA2322660A1 Enhanced anti-tumor immunity
09/23/1999CA2322659A1 Compositions and methods for gene-based vaccines to provoke t cell responses
09/23/1999CA2322619A1 Medium and method for viral propagation and growth
09/23/1999CA2321113A1 Anti-inositolphosphoglycan monoclonal antibodies
09/23/1999CA2321091A1 An equine neospora isolate and its uses
09/23/1999CA2288679A1 Process for the production of virus in cell cultures
09/22/1999EP0943684A2 Frizzled-like polypeptides and polynucleotides
09/22/1999EP0943683A1 Human vanilloid receptor homologue Vanilrep1
09/22/1999EP0943681A1 Live attenuated salmonella vaccine
09/22/1999EP0943625A1 Antibodies, production method of the antibodies, hybridomas which produce the antibodies, production method of the hybridomas and antigen proteins recognized by the antibodies
09/22/1999EP0943015A2 Method and apparatus for preparing sample cartridges for a particle acceleration device
09/22/1999EP0942998A1 Notch
09/22/1999EP0942997A1 Chimeric ltb vaccines
09/22/1999EP0942988A1 Hiv envelope polypeptides and vaccine
09/22/1999EP0942987A1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
09/22/1999EP0942984A2 C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE)
09/22/1999EP0942983A2 $i(STREPTOCOCCUS PNEUMONIAE) ANTIGENS AND VACCINES
09/22/1999EP0942982A1 Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof
09/22/1999EP0942980A1 Tumor-associated kazal inhibitor with pec-60 homology
09/22/1999EP0942976A1 Human sqm1 protein homolog comprising a cell adhesion protein
09/22/1999EP0942975A1 Glaucoma-associated protein and corresponding nucleic acid and their therapeutic and diagnostic uses
09/22/1999EP0942970A1 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof
09/22/1999EP0942968A2 TRANSGENIC MAMMALS HAVING HUMAN IG LOCI INCLUDING PLURAL V H? AND V$g(k) REGIONS AND ANTIBODIES PRODUCED THEREFROM
09/22/1999EP0942964A2 Thermostable polymerases having altered fidelity
09/22/1999EP0942959A1 Transgenic non-human animals capable of producing heterologous antibodies
09/22/1999EP0942933A1 Human kdel receptor
09/22/1999EP0942928A1 Subunit respiratory syncytial virus vaccine preparation
09/22/1999EP0942927A1 Procedure for the purification and refolding of hpv proteins
09/22/1999EP0942780A1 Coated particles, methods of making and using
09/22/1999EP0942750A1 Anti-class ii mhc binding agents for use in xenotransplantation
09/22/1999EP0942748A1 Env-glycoprotein vaccine for protection of htlv-i and -ii infection
09/22/1999EP0942747A1 Postinfection human immunodeficiency virus (hiv) vaccination therapy
09/22/1999EP0620741B1 Cytotoxic drug therapy
09/22/1999EP0594743B1 Continuous cell line and vaccine against avian coccidia
09/22/1999EP0540525B1 Method of preparation of vaccines, and the use of the vaccines thus prepared
09/22/1999CN1229439A Fusion polypeptides comprising an IgE-binding domain and a HSA component, and their diagnostic and therapeutic uses
09/22/1999CN1229437A Polypeptides useful as immunotherapeutic agent and method of polypeptides preparation
09/22/1999CN1229436A Antigen binding fragments that specifically detect cancer cells, nucleotindes encoding the fragments, and use thereof for the prophylaxis and detection of cancers
09/22/1999CN1229434A Method of attenuating viruses
09/22/1999CN1229414A Multivalent compounds for cross-linking receptors and uses thereof
09/22/1999CN1229359A Dendritic cell stimulatory factor
09/22/1999CN1229358A Method for generating bi-RNA-virus from synthetic RNA transcripts
09/21/1999US5955596 NucA protein of Haemophilus influenzae and the gene encoding that protein
09/21/1999US5955592 Nucleotide and amino acid sequences; for diagnosis of susceptiblity to cancer or diabetes
09/21/1999US5955585 Catalytic condensation method for the preparation of chlorophyll and bacteriochlorophyll derivatives
09/21/1999US5955580 Vaccines for nontypable haemophilus influenzae
09/21/1999US5955579 Islet-specific homeoprotein and transcriptional regulator of insulin gene expression, HOXB13
09/21/1999US5955503 Modified amino acid compounds useful as carriers in the delivery of biologically active agents such as, for example, bioactive peptides and the like
09/21/1999US5955434 N-terminal fmoc-protected peptide combinations that form gels in water
09/21/1999US5955366 Polynucleotides encoding cytokine suppressive anti-inflammatory drug binding proteins
09/21/1999US5955364 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
09/21/1999US5955359 Method of growing granulocytic ehrlichiae of the Ehrlichia phagocytophila genogroup in promyelocytic leukemia cell culture, and preparing antigens and vaccines of said granulocytic ehrlichiae
09/21/1999US5955356 Nucleic acids, vectors, and host cells including mycobacterium derived sequences
09/21/1999US5955342 Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region
09/21/1999US5955338 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase
09/21/1999US5955337 Lyase enzyme which can be used to screen fungicidal compounds
09/21/1999US5955333 Transferring selectable markers into protozoans or yeast by homologus recombination at specific positions in the genome with the use of a vector; replacement of virulence gene; vacine development
09/21/1999US5955309 Polynucleotide encoding G-protein coupled receptor (H7TBA62)
09/21/1999US5955304 DivIB
09/21/1999US5955303 Human chemokine receptor-like protein
09/21/1999US5955300 Immunoglobulin fusion protein with amino acid replacements immunosuppressant against autoimmune diseases; useful in the therapeutic treament of melanomas and leukemias
09/21/1999US5955299 For diagnosis and treatment of systemic lupus erythematosus; antisense agents
09/21/1999US5955291 Antibodies against extrcellular domain; useful as a diagnostic tool of tumor formation; monitoring of wound healing; imaging agents
09/21/1999US5955283 Dna probe useful in diagnosis of diseases related to ion transport in the central and or automonic neverous system; alzheimer's/parkindon's/huntington's diseases
09/21/1999US5955278 Polynucleotide sequences coding human protein synthesis controller; useful in diagnosis, prevention, and therapy for apoptosis; antiinflammatory agents; anticarcinogenic agents; antiproliferative agents
09/21/1999US5955260 Antibodies that bind viral proteins that share homogeneity; for diagnostic immunoassay of virus in sample
09/21/1999US5955090 Immunogenic hybrid protein OprF-OprI derived from Pseudomonas aeruginosa membrane proteins
09/21/1999US5955089 Streptococcus for vaccines
09/21/1999US5955088 Pharmaceutical compsition of herpes simplex virus type-1 (HSV-1), glycoproteins
09/21/1999US5955087 Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
09/21/1999US5955080 Self-adjuvanting peptide vaccine delivery system and production thereof
09/21/1999US5955079 Composition comprising high molecular weight primary carrier, secondary carrier comprising t-dependent antigen conjugated to primary carrier, having enhanced antibody response to both carriers
09/21/1999US5955077 Tuberculosis vaccine
09/21/1999US5955076 Immunoactive peptides and antibodies and their use in anti-allergy treatment
09/21/1999US5955075 Molecular hybridization, genetic engineering
09/21/1999US5955074 Directed human immune globulin for the prevention and treatment of staphylococcal infections
09/21/1999US5955072 Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide
09/21/1999CA2098773C Recombinant coccidia and its use in a vaccine
09/21/1999CA2045761C Ws7622a mono- or di- sulfate, process for preparation thereof and use thereof
09/21/1999CA1340762C Recombinant birth control vaccine
09/20/1999CA2232812A1 Interleukin-1 receptor antagonist beta (il-1ra.beta.)
09/16/1999WO1999046597A1 Assay of igfbp complex
09/16/1999WO1999046594A2 C-myc coding region determinant-binding protein (crd-bp)
09/16/1999WO1999046574A2 Antibodies for assessing protein post-translational modification status and methods of making and using the same
09/16/1999WO1999046392A1 Methods and compositions of chemokine-tumor antigen fusion proteins as cancer vaccines
09/16/1999WO1999046390A1 Chitinase chitin-binding fragments
09/16/1999WO1999046379A2 Human receptor proteins; related reagents and methods
09/16/1999WO1999046375A2 Human nucleic acid sequences from prostate tissue
09/16/1999WO1999046365A1 Methods and compositions for the selective expansion of gamma/delta t-cells
09/16/1999WO1999046300A1 Products comprising inactivated yeasts or moulds and active vhh-type antibodies
09/16/1999WO1999046293A1 A zinc finger protein derived from hematopoietic cells
09/16/1999WO1999046292A1 A human p18 gene (cbdara04)
09/16/1999WO1999046291A1 A human glia maturation factor (gmf) beta homolog gene (cbfboe11)
09/16/1999WO1999046290A1 A human angiotensin ii/vasopressin receptor (aii/avp) like gene (cbdakd01)
09/16/1999WO1999046281A2 Novel polypeptides and nucleic acids encoding the same
09/16/1999WO1999046275A1 REPLICATIVE HELICASE dnaB OF $i(STAPHYLOCOCCUS AUREUS)